Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Sigurd Lax"'
Autor:
Qing Zhou, Samantha O. Perakis, Peter Ulz, Sumitra Mohan, Jakob M. Riedl, Emina Talakic, Sigurd Lax, Martin Tötsch, Gerald Hoefler, Thomas Bauernhofer, Martin Pichler, Armin Gerger, Jochen B. Geigl, Ellen Heitzer, Michael R. Speicher
Publikováno v:
Genome Medicine, Vol 12, Iss 1, Pp 1-17 (2020)
Abstract Background Bevacizumab, a monoclonal antibody against soluble VEGFA, is an approved and commonly administered anti-angiogenic drug in patients with metastasized colorectal cancer (mCRC). The survival benefit of anti-VEGF therapy in mCRC pati
Externí odkaz:
https://doaj.org/article/fc254d7ec85e448b9fbac1d663e3b0b7
Autor:
Moritz Schütte, Thomas Risch, Nilofar Abdavi-Azar, Karsten Boehnke, Dirk Schumacher, Marlen Keil, Reha Yildiriman, Christine Jandrasits, Tatiana Borodina, Vyacheslav Amstislavskiy, Catherine L. Worth, Caroline Schweiger, Sandra Liebs, Martin Lange, Hans- Jörg Warnatz, Lee M. Butcher, James E. Barrett, Marc Sultan, Christoph Wierling, Nicole Golob-Schwarzl, Sigurd Lax, Stefan Uranitsch, Michael Becker, Yvonne Welte, Joseph Lewis Regan, Maxine Silvestrov, Inge Kehler, Alberto Fusi, Thomas Kessler, Ralf Herwig, Ulf Landegren, Dirk Wienke, Mats Nilsson, Juan A. Velasco, Pilar Garin-Chesa, Christoph Reinhard, Stephan Beck, Reinhold Schäfer, Christian R. A. Regenbrecht, David Henderson, Bodo Lange, Johannes Haybaeck, Ulrich Keilholz, Jens Hoffmann, Hans Lehrach, Marie-Laure Yaspo
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-19 (2017)
The heterogeneity of colorectal cancer has important clinical and therapeutic implications. Here the authors analysed the responses of a large biobank of organoids and xenografts derived from colorectal patients to a panel of clinically relevant ther
Externí odkaz:
https://doaj.org/article/00f477ba693042c6918f1164e120c8e4
Autor:
Verena Tiran, Stefanie Stanzer, Ellen Heitzer, Michael Meilinger, Christopher Rossmann, Sigurd Lax, Oleksiy Tsybrovskyy, Nadia Dandachi, Marija Balic
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175223 (2017)
A common symptom during late stage breast cancer disease is pleural effusion, which is related to poor prognosis. Malignant cells can be detected in pleural effusions indicating metastatic spread from the primary tumor site. Pleural effusions have be
Externí odkaz:
https://doaj.org/article/dab9aee4402c43888242fe7455814733
Autor:
Johannes Haybaeck, Sigurd Lax, Edgar Petru, Martin Pichler, Elisabeth Smolle, Valentin Taucher
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 5, Pp 9536-9555 (2013)
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-based chemotherapy is poor in some patients and, thus, current research is focusing on new therapy options. The various histological types of OC are characterize
Externí odkaz:
https://doaj.org/article/03ee6e08897d41fa8d4c4adacec7cbf1
Autor:
Sumitra Mohan, Ellen Heitzer, Peter Ulz, Ingrid Lafer, Sigurd Lax, Martina Auer, Martin Pichler, Armin Gerger, Florian Eisner, Gerald Hoefler, Thomas Bauernhofer, Jochen B Geigl, Michael R Speicher
Publikováno v:
PLoS Genetics, Vol 10, Iss 3, p e1004271 (2014)
Monoclonal antibodies targeting the Epidermal Growth Factor Receptor (EGFR), such as cetuximab and panitumumab, have evolved to important therapeutic options in metastatic colorectal cancer (CRC). However, almost all patients with clinical response t
Externí odkaz:
https://doaj.org/article/ca1ee54617a7403a9ad5c1ba8a23efa6
Autor:
Christian F. Singer, Frederik Holst, Stefan Steurer, Eike Burandt, Sigurd Lax, Raimund Jakesz, Margaretha Rudas, Herbert Stöger, Richard Greil, Guido Sauter, Martin Filipits, Ronald Simon, Michael Gnant
Publikováno v:
Cancer Research. 83:P2-11
Purpose: Estrogen receptor (ER) expression predicts response to endocrine therapy and is a prognostic biomarker. However, no ER-associated biomarker is able to identify patients with particularly favorable outcome among ER+ tumors. We investigated th
Autor:
David Cibula, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Felix, Daniela Fischerová, Daniela Jahnn-Kuch, Florence Joly, Christhardt Kohler, Sigurd Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Mr Raj Naik, Remi A Nout, Ana Oaknin, Fedro Peccatori, Jan Persson, Denis Querleu, Sandra Rubio Bernabé, Maximilian P. Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Lindegaard
Publikováno v:
Cibula, D, Rosaria Raspollini, M, Planchamp, F, Centeno, C, Chargari, C, Felix, A, Fischerová, D, Jahnn-Kuch, D, Joly, F, Kohler, C, Lax, S, Lorusso, D, Mahantshetty, U, Mathevet, P, Raj Naik, M, Nout, R A, Oaknin, A, Peccatori, F, Persson, J, Querleu, D, Rubio Bernabé, S, Schmid, M P, Stepanyan, A, Svintsitskyi, V, Tamussino, K, Zapardiel, I & Lindegaard, J 2023, ' ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023 ', Radiotherapy and Oncology, vol. 184, 109682 . https://doi.org/10.1016/j.radonc.2023.109682
Funding Information: The authors thank ESGO, ESTRO, and ESP for their support. The authors also thank the 155 international reviewers (physicians and patient representatives, see Appendix 2 in Online Supplemental File 2) for their valuable comments a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65f0323ffe81b41bb05a0de9ce3192b
https://pure.au.dk/portal/da/publications/esgoestroesp-guidelines-for-the-management-of-patients-with-cervical-cancer--update-2023(a7a7a4ad-5b3a-4fb0-8db3-a3c06ec7558b).html
https://pure.au.dk/portal/da/publications/esgoestroesp-guidelines-for-the-management-of-patients-with-cervical-cancer--update-2023(a7a7a4ad-5b3a-4fb0-8db3-a3c06ec7558b).html
Autor:
Michael R. Speicher, Jochen B. Geigl, Thomas Bauernhofer, Sabine Riethdorf, Klaus Pantel, Hellmut Samonigg, Heinz Sill, Florian Eisner, Gerald Höfler, Carolin Lackner, Oliver Mauermann, Julie Waldispuehl-Geigl, Sigurd Lax, Eva Maria Hoffmann, Peter Ulz, Martin Pichler, Christin Gasch, Martina Auer, Ellen Heitzer
PDF file - 868K, Ratio bin distributions for CTC12 (a) and CTC03 (b) from patient #6. The large bin 13 peak indicates the frequency of oligonucleotides with balanced ratio values. The bins to the right of 13 represent the bins for oligonucleotides wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea437c6888af3ac054ca1f47004d381
https://doi.org/10.1158/0008-5472.22398300
https://doi.org/10.1158/0008-5472.22398300
Autor:
Michael R. Speicher, Jochen B. Geigl, Thomas Bauernhofer, Sabine Riethdorf, Klaus Pantel, Hellmut Samonigg, Heinz Sill, Florian Eisner, Gerald Höfler, Carolin Lackner, Oliver Mauermann, Julie Waldispuehl-Geigl, Sigurd Lax, Eva Maria Hoffmann, Peter Ulz, Martin Pichler, Christin Gasch, Martina Auer, Ellen Heitzer
PDF file - 95K, List of 68 genes, which, according to the COSMIC database, are frequently mutated in colorectal carcinoma (CRC) and analyzed in our study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b6d8d30c3e6a4af6e490764f2583e7
https://doi.org/10.1158/0008-5472.22398288
https://doi.org/10.1158/0008-5472.22398288
Autor:
Michael R. Speicher, Jochen B. Geigl, Thomas Bauernhofer, Sabine Riethdorf, Klaus Pantel, Hellmut Samonigg, Heinz Sill, Florian Eisner, Gerald Höfler, Carolin Lackner, Oliver Mauermann, Julie Waldispuehl-Geigl, Sigurd Lax, Eva Maria Hoffmann, Peter Ulz, Martin Pichler, Christin Gasch, Martina Auer, Ellen Heitzer
PDF file - 1303K, Evaluation of available material from patient #9. (a-b) Array CGH profiles of the primary tumor (a) and metastasis (peritoneal carcinomatosis) (b). Regarding the color bar codes please see legend to Supp. Fig. 2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734922995c2c4dfe4759f70b2080f593
https://doi.org/10.1158/0008-5472.22398312
https://doi.org/10.1158/0008-5472.22398312